Firebrick Pharma Launches Share Purchase Plan

Firebrick Pharma Limited (AU:FRE) has released an update.

Firebrick Pharma Limited has announced the opening of its Share Purchase Plan, aiming to raise up to $2 million by offering eligible shareholders the opportunity to buy new shares without transaction costs. The innovative pharmaceutical company, known for its PVP-I nasal spray, is extending this offer until October 7, 2024, and details are available on their website and through the provided contact channels.

For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.